VERSARTIS INC's ticker is VSAR and the CUSIP is 92529L102. A total of 56 filers reported holding VERSARTIS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $0 | -100.0% | 235 | -99.5% | 0.00% | – |
Q2 2018 | $95,000 | +691.7% | 46,881 | +582.2% | 0.00% | – |
Q1 2018 | $12,000 | -53.8% | 6,872 | -40.5% | 0.00% | – |
Q4 2017 | $26,000 | -98.4% | 11,541 | -98.2% | 0.00% | -100.0% |
Q3 2017 | $1,598,000 | +2859.3% | 651,854 | +20853.2% | 0.00% | – |
Q2 2017 | $54,000 | +45.9% | 3,111 | +79.5% | 0.00% | – |
Q1 2017 | $37,000 | +8.8% | 1,733 | -23.8% | 0.00% | – |
Q4 2016 | $34,000 | +580.0% | 2,275 | +426.6% | 0.00% | – |
Q3 2016 | $5,000 | -16.7% | 432 | -19.6% | 0.00% | – |
Q2 2016 | $6,000 | +500.0% | 537 | +262.8% | 0.00% | – |
Q1 2016 | $1,000 | -85.7% | 148 | -67.8% | 0.00% | – |
Q4 2015 | $7,000 | -93.3% | 460 | -95.2% | 0.00% | – |
Q3 2015 | $105,000 | +1400.0% | 9,607 | +1848.7% | 0.00% | – |
Q2 2015 | $7,000 | -41.7% | 493 | -21.9% | 0.00% | – |
Q1 2015 | $12,000 | 0.0% | 631 | +12.1% | 0.00% | – |
Q4 2014 | $12,000 | +200.0% | 563 | +149.1% | 0.00% | – |
Q3 2014 | $4,000 | 0.0% | 226 | +48.7% | 0.00% | – |
Q2 2014 | $4,000 | – | 152 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 2,296,471 | $51,556,000 | 25.09% |
Aisling Capital LLC | 1,994,568 | $44,778,000 | 6.79% |
Opaleye Management Inc. | 235,000 | $5,276,000 | 2.67% |
Perceptive Advisors | 931,171 | $19,740,000 | 1.66% |
HealthCor Management, L.P. | 875,000 | $19,644,000 | 1.10% |
Cormorant Asset Management, LP | 200,000 | $4,490,000 | 0.69% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 644,150 | $14,461,000 | 0.63% |
RA Capital Management | 231,267 | $5,192,000 | 0.56% |
Baker Brothers Advisors | 2,281,744 | $51,225,000 | 0.52% |
PFM Health Sciences, LP | 869,463 | $19,519,000 | 0.46% |